(Q46256361)

20 December 2017

title

Comparative effects of Rauwolfia vomitoria and chlorpromazine on locomotor behaviour and anxiety in mice (English)

1 reference

20 December 2017

1 reference

1

Sunday Agba Bisong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800668

3 July 2024

author name string

Richard Brown

2

1 reference

20 December 2017

Eme Effiom Osim

3

1 reference

20 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20800668

3 July 2024

publication date

26 August 2010

1 reference

20 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0378874110006069?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

https://api.elsevier.com/content/article/PII:S0378874110006069?httpAccept=text/plain

3 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Journal of Ethnopharmacology

3 July 2024

published in

1 reference

20 December 2017

volume

132

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

334-339

1 reference

20 December 2017

The mouse light/dark box test

cites work

8

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Tissue lipid lowering-effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foilage and Citrus aurantium fruit

3 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Role of an enriched environment on the restoration of behavioral deficits in Lurcher mutant mice.

3 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.

3 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Anxiolytic properties of the antipsychotic alkaloid alstonine

3 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

The alkaloid alstonine: a review of its pharmacological properties

3 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Finding a fit: psychiatric pluralism in south India and its implications for WHO studies of mental disorder

3 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Use of herbal medicine for treating psychiatric disorders in Japan

3 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Antiinflammatory activity of a Ghanaian antiarthritic herbal preparation: III.

3 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Catecholamine depletion by reserpine blocks the anxiolytic actions of ethanol in the rat.

3 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Historical approach to reserpine discovery and its introduction in psychiatry

3 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction

3 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management

3 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

3 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

Mental disorders and the use of alternative medicine: results from a national survey.

3 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JEP.2010.08.045

3 July 2024

Identifiers

1 reference

20 December 2017

1 reference

20 December 2017